Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease

Cites (244)

Items 201–243 of 243

1. Vascular Oxidative Stress and Mitochondrial Failure in the Pathobiology of Alzheimer’s Disease: A New Approach to Therapy
   Marta Sochocka, Effrosyni Koutsouraki, Kazimierz Gąsiorowski, Jerzy Leszek · 2013 · CNS & Neurological Disorders - Drug Targets
2. Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
   Richard A. Harris, Lauren C. Tindale, Robert C. Cumming · 2014 · Biogerontology
3. Role of peroxisome proliferator-activated receptor γ in amyloid precursor protein processing and amyloid β-mediated cell death
   Cristina d’Abramo, Sara Massone, Jean-Marc Zingg, Antonio Pizzuti, Philippe Marambaud, Bruno Dalla Piccola, Angelo Azzi, Umberto Maria Marinari, Maria Adelaide Pronzato, Roberta Ricciarelli · 2005 · Biochemical Journal
4. Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research
   William H. Thies · 2011 · Alzheimer s & Dementia
5. Repression of β-catenin signaling by PPARγ ligands
   Desheng Lu, Dennis Anthony Carson · 2010 · European Journal of Pharmacology
6. CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3β/β-Catenin Signaling
   Stefania Trazzi, Martin Steger, Valentina Maria Mitrugno, Renata Bartesaghi, Elisabetta Ciani · 2010 · Journal of Biological Chemistry
7. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
   Natalie E. Zlebnik, Joseph F. Cheer · 2016 · Annual Review of Neuroscience
8. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
   Dagmar E. Ehrnhoefer, Bibiana K. Y. Wong, Michael R. Hayden · 2011 · Nature Reviews Drug Discovery
9. Wnt/β-catenin and its Diverse Physiological Cell Signaling Pathways in Neurodegenerative and Neuropsychiatric Disorders
   Lena Al‐Harthi · 2012 · Journal of Neuroimmune Pharmacology
10. The Forkhead Transcription Factor FOXO3a Controls Microglial Inflammatory Activation and Eventual Apoptotic Injury through Caspase 3
    Yan Shang, Zhao Zhong Chong, Jinling Hou, Kenneth Maiese · 2009 · Current Neurovascular Research
11. The dynamic role of beta-catenin in synaptic plasticity
    Kimberly A. Maguschak, Kerry James Ressler · 2011 · Neuropharmacology
12. Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells
    Maria Antonietta Ajmone‐Cat, Maria Cristina D’Urso, Giorgia di Blasio, Maria Stefania Brignone, Roberta De Simone, Luisa Minghetti · 2015 · Brain Behavior and Immunity
13. Evidence for Participation of Aluminum in Neurofibrillary Tangle Formation and Growth in Alzheimer's Disease
    Judie R. Walton · 2010 · Journal of Alzheimer s Disease
14. A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
    Fatima Djouadi, Yves Lecarpentier, Jean‐Louis Hébert, Philippe Charron, Jean Bastin, Catherine Coirault · 2009 · Cardiovascular Research
15. NFκB signaling regulates embryonic and adult neurogenesis
    Yonggang Zhang, Wenhui Hu · 2012 · Frontiers in Biology
16. Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases
    Xiang, Wang, Chao, Zhang-Yong, Feng, Du-Yi · 2015 · Reviews in the Neurosciences
17. Cross-Regulation Between WNT and NF-κB Signaling Pathways
    Qiang Du, David A. Geller · 2010 · Forum on Immunopathological Diseases and Therapeutics
18. Functional Cross-talk between β-Catenin and NFκB Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin
    Shahid Umar, Shubhashish Sarkar, Yu Wang, Pomila Singh · 2009 · Journal of Biological Chemistry
19. Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis
    Yves Lecarpentier, Alexandre Vallée · 2016 · Frontiers in Neurology
20. The therapeutic potential of the endocannabinoid system for Alzheimer's disease
    Tim Karl, David Cheng, Brett Garner, Jonathon Carl Arnold · 2012 · Expert Opinion on Therapeutic Targets
21. Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies
    Sara Jane Ward, Robert B. Raffa · 2011 · Obesity
22. Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease
    Juan Manuel Zolezzi, Nibaldo C. Inestrosa · 2017 · Frontiers in Immunology
23. Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury
    P. Stahel, Wade R. Smith, Jay Bruchis, C. Rabb · 2008 · PPAR Research
24. Global Analysis of Phosphorylation of Tau by the Checkpoint Kinases Chk1 and Chk2 in vitro
    Jhoana Mendoza, Michiko Sekiya, Taizo Taniguchi, Koichi Iijima, Rong Wang, Kanae Ando · 2013 · Journal of Proteome Research
25. Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β-peptide
    Adi Shruster, Hagit Eldar-Finkelman, Eldad Melamed, Daniel Offen · 2010 · Journal of Neurochemistry
26. Peroxisome Proliferator-activated Receptors and Alzheimer's Disease: Hitting the Blood–Brain Barrier
    Juan Manuel Zolezzi, Nibaldo C. Inestrosa · 2013 · Molecular Neurobiology
27. Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of A lzheimer's Disease
    Nibaldo C. Inestrosa, Juvenal A. Ríos, Pedro Cisternas, Cheril Tapia‐Rojas, Daniela S. Rivera, Nady Braidy, Juan Manuel Zolezzi, Juan Alejandro Godoy, Francisco J. Carvajal, Álvaro O. Ardiles et al. · 2014 · Brain Pathology
28. Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy
    Tapan Behl, Ishneet Kaur, Heena Goel, Anita Kotwani · 2016 · Life Sciences
29. Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease
    Stanley Isaac Rapoport · 2003 · Neurotoxicity Research
30. Functional Variants in DPYSL2 Sequence Increase Risk of Schizophrenia and Suggest a Link to mTOR Signaling
    Yaping Liu, Xuan Pham, Lilei Zhang, Pei-Lung Chen, Grzegorz M. Burzynski, David M. McGaughey, Shan He, John A. McGrath, Paula S Wolyniec, Margaret Daniele Fallin et al. · 2014 · G3 Genes Genomes Genetics
31. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells
    Ming‐Chang Chiang, Yi‐Chuan Cheng, Christopher J.B. Nicol, Kuan‐Hung Lin, Chiahui Yen, Shiang‐Jiuun Chen, Rong Huang · 2015 · Experimental Cell Research
32. Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies
    Silvia Santamaría Santamaría, Nerea Sánchez, Mariano Sanz, José A. García‐Sanz · 2016 · Clinical Oral Investigations
33. N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte
    Songbo Wang, Qi Xu, Gang Shu, Lina Wang, Ping Gao, Qianyun Xi, Yongliang Zhang, Qingyan Jiang, Xiaotong Zhu · 2015 · Biochemical and Biophysical Research Communications
34. Survival activity of troglitazone in rat motoneurones
    Chiaki Nishijima, Kosuke Kimoto, Yoshihiro Arakawa · 2001 · Journal of Neurochemistry
35. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from β-amyloid neurotoxicity by acting on Wnt signaling components
    Ginny G. Farı́as, Juan Alejandro Godoy, Mary Carmen Vázquez, Rellie Adani, Haim Meshulam, Jesús Ávila, Gabi Amitai, Nibaldo C. Inestrosa · 2004 · Neurobiology of Disease
36. Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway
    Jiajun Liu, Xuejun Dai, Yan Xu, Peiqing Liu, Yong Zhang, Xiaodan Liu, Zhigang Fang, Dong-Jun Lin, Ruozhi Xiao, Renwei Huang et al. · 2011 · Cell Biochemistry and Biophysics
37. LRP5 associates with specific subsets of macrophages: Molecular and functional effects
    María Borrell-Pagés, July Carolina Romero, Javier Crespo, Oriol Juan‐Babot, Lina Badimón · 2015 · Journal of Molecular and Cellular Cardiology
38. Neuroinflammation as a possible link between cannabinoids and addiction
    L. C. M. Rodrigues, Pedro Henrique Gobira, Antônio Carlos de Oliveira, Renan Pelição, Antônio Lúcio Teixeira, Fabrício A. Moreira, Alline Cristina Campos · 2013 · Acta Neuropsychiatrica
39. Further Evidence on Mitochondrial Targeting of β-Amyloid and Specificity of β-Amyloid-Induced Mitotoxicity in Neurons
    Laurent Tillement, Laurent Lecanu, Vassilios Papadopoulos · 2011 · Neurodegenerative Diseases
40. PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways
    Yves Lecarpentier, VICTOR A. CLAES, Jean‐Louis Hébert · 2010 · PPAR Research
41. Peroxisome proliferator activated receptor gamma (PPARγ) as a therapeutic target for improvement of cognitive performance in Fragile-X
    Mohammad Jodeiri Farshbaf, Kamran Ghaedi, Mahsa Shirani, Mohammad Hossein Nasr‐Esfahani · 2013 · Medical Hypotheses
42. Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
    Ran Yi, Benwei Chen, Jing Zhao, Xiaorong Zhan, Liming Zhang, Xiao-Min Liu, Qi Dong · 2013 · Journal of Molecular Neuroscience
43. The effect of DNA damage on the formation of protein/DNA complexes
    Azemat J. Parsian, Margo C. Funk, Ting Y. Tao, Clayton R. Hunt · 2002 · Mutation research. Fundamental and molecular mechanisms of mutagenesis